Skip to main content
Erschienen in: World Journal of Surgery 1/2017

22.08.2016 | Innovative Surgical Techniques Around the World

Metabolic Surgery for Diabetes Treatment: Sleeve Gastrectomy or Gastric Bypass?

verfasst von: Wei-Jei Lee, Keong Chong, Lwin Aung, Shu-Chun Chen, Kong-Han Ser, Yi-Chih Lee

Erschienen in: World Journal of Surgery | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Bariatric surgery has gained reputation for its metabolic effect and is increasingly being performed to treat type 2 diabetes mellitus (T2DM). However, there is still a gray area regarding the choice of surgical procedure according to patient characteristics due to inadequate evidences, so far. We aim to compare the efficacy of two most commonly performed bariatric/metabolic surgeries, sleeve gastrectomy (SG) and gastric bypass (GB) with regard to remission of T2DM after surgery.

Methods

Outcomes of 579 (349 female and 230 male) patients who had undergone SG (109) or GB (470) for the treatment of T2DM with 1-year follow-up were assessed. The remission of T2DM after SG or GB surgery was evaluated in matched groups using the ABCD scoring system. The ABCD score is composed of the age, BMI, C-peptide levels and duration of T2DM (years).

Results

The weight loss of the SG patient at 1 year after surgery was similar to the GB patients [26.3 (1.1) vs. 32.6 (1.2) %; p = 0.258]. The mean BMI decreased from 35.7 (7.2) to 28.3 (3.7) Kg/m2 in SG patients at 1 year after surgery and decreased from 36.9 (7.2) to 26.7 (4.5) Kg/m2 in the GB patients. The mean HbA1c decreased from 8.8 to 6.1 % of the SG group and from 8.6 to 5.9 % of the GB group. Sixty-one (56.0 %) patients of the SG group and 300 (63.8 %) of the GB group achieved complete remission of T2DM (HbA1c < 6.0 %) at 1 year after surgery without statistical difference. However, GB exhibited significantly better glycemic control than the SG surgery in groups stratified by different ABCD score. At 5 year after surgery, GB had a better remission of T2DM than SG (53.1 vs. 35.3 %; p = 0.055).

Conclusions

In conclusion, although both SG and GB are effective metabolic surgery, GB carries a higher power on T2DM remission than SG. ABCD score is useful in T2DM patient classification and selection for different procedures.
Literatur
1.
Zurück zum Zitat Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimated of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–312CrossRefPubMed Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimated of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–312CrossRefPubMed
2.
Zurück zum Zitat Zimmer P, Alberti KG, Shaw J (2013) Global and societal implications of the diabetes epidemic. JAMA 414:782–787 Zimmer P, Alberti KG, Shaw J (2013) Global and societal implications of the diabetes epidemic. JAMA 414:782–787
3.
Zurück zum Zitat American Diabetes Association (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care 13:596–615CrossRef American Diabetes Association (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care 13:596–615CrossRef
4.
Zurück zum Zitat Gerstein HC, Miller ME, Byington RP et al (2008) Action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559CrossRefPubMed Gerstein HC, Miller ME, Byington RP et al (2008) Action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559CrossRefPubMed
5.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737CrossRefPubMed Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737CrossRefPubMed
6.
Zurück zum Zitat Sjostrom L, Narbro K, Sjostrom D et al (2007) Effect of bariatric surgery on mortality in Swedish obese subjects. NEJM 357:741–752CrossRefPubMed Sjostrom L, Narbro K, Sjostrom D et al (2007) Effect of bariatric surgery on mortality in Swedish obese subjects. NEJM 357:741–752CrossRefPubMed
7.
Zurück zum Zitat Lee WJ, Chong K, Ser KH et al (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143–148CrossRefPubMed Lee WJ, Chong K, Ser KH et al (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143–148CrossRefPubMed
8.
Zurück zum Zitat Cohen RV, Pinheiro JC, Schiavon C et al (2012) Effective of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 35:1420–1428CrossRefPubMedPubMedCentral Cohen RV, Pinheiro JC, Schiavon C et al (2012) Effective of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 35:1420–1428CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Schauer PR, Kashyap SR, Wolski K et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366:1567–1576CrossRefPubMedPubMedCentral Schauer PR, Kashyap SR, Wolski K et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366:1567–1576CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Ikramuddin S, Korner J, Lee WJ et al (2013) Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The diabetes surgery study randomized clinical trial. JAMA 309:2240–2249CrossRefPubMedPubMedCentral Ikramuddin S, Korner J, Lee WJ et al (2013) Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The diabetes surgery study randomized clinical trial. JAMA 309:2240–2249CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Liang Z, Wu Q, Chen B, Yu P, Zhao H, Quyang X (2013) Effect of laparoscopic Roux-en-Y gastric bypass for type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract 101:50–56CrossRefPubMed Liang Z, Wu Q, Chen B, Yu P, Zhao H, Quyang X (2013) Effect of laparoscopic Roux-en-Y gastric bypass for type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract 101:50–56CrossRefPubMed
12.
Zurück zum Zitat Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med 370:2002–2013CrossRefPubMed Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med 370:2002–2013CrossRefPubMed
13.
Zurück zum Zitat Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23:427–436CrossRefPubMed Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23:427–436CrossRefPubMed
14.
Zurück zum Zitat Peterli R, Borbely Y, Ker B et al (2013) Early results of the Swiss multicentre bypass or sleeve study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg 258:690–695CrossRefPubMedPubMedCentral Peterli R, Borbely Y, Ker B et al (2013) Early results of the Swiss multicentre bypass or sleeve study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg 258:690–695CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Alexandrou A, Arment E, Kouskouni E, Tsoka E, Diamantis T, Lambrinoudaki I (2014) Cross-sectional long-term micronutrient deficiencies after sleeve gastrectomy versus Roux-en-Y gastric bypass: a pilot study. Surg Obes Relat Dis 10:262–268CrossRefPubMed Alexandrou A, Arment E, Kouskouni E, Tsoka E, Diamantis T, Lambrinoudaki I (2014) Cross-sectional long-term micronutrient deficiencies after sleeve gastrectomy versus Roux-en-Y gastric bypass: a pilot study. Surg Obes Relat Dis 10:262–268CrossRefPubMed
16.
Zurück zum Zitat Vix M, Liu KH, Diana M, D’Urso A, Mutter D, Marescaux J (2014) Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial. Surg Endoscoc 28:821–826CrossRef Vix M, Liu KH, Diana M, D’Urso A, Mutter D, Marescaux J (2014) Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial. Surg Endoscoc 28:821–826CrossRef
17.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P et al (2015) Bariatric surgery worldwide 2013. Obes Surg 25:1822–1832CrossRefPubMed Angrisani L, Santonicola A, Iovino P et al (2015) Bariatric surgery worldwide 2013. Obes Surg 25:1822–1832CrossRefPubMed
18.
Zurück zum Zitat Transtulli S, Desiderio J, Guarino S et al (2013) Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis 9:816–829CrossRef Transtulli S, Desiderio J, Guarino S et al (2013) Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis 9:816–829CrossRef
20.
Zurück zum Zitat Lee WJ, Yu PJ, Wang W et al (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 242:20–28CrossRefPubMedPubMedCentral Lee WJ, Yu PJ, Wang W et al (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 242:20–28CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ser KH, Lee WJ, Lee YC et al (2010) Experience in laparoscopic sleeve gastrectomy for morbid obese Taiwanese: staple-line reinforcement is important for preventing leakage. Surg Endosc 16:2253–2259CrossRef Ser KH, Lee WJ, Lee YC et al (2010) Experience in laparoscopic sleeve gastrectomy for morbid obese Taiwanese: staple-line reinforcement is important for preventing leakage. Surg Endosc 16:2253–2259CrossRef
22.
Zurück zum Zitat Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC et al (2013) Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis 9:379–384CrossRefPubMed Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC et al (2013) Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis 9:379–384CrossRefPubMed
23.
Zurück zum Zitat Lee WJ, Lee KT, Kasama K et al (2015) The effect and predictive score of gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus patients with BMI < 30 Kg/m2. Obes Surg 25:1772–1778CrossRefPubMed Lee WJ, Lee KT, Kasama K et al (2015) The effect and predictive score of gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus patients with BMI < 30 Kg/m2. Obes Surg 25:1772–1778CrossRefPubMed
24.
Zurück zum Zitat Lakadawala M, Shaikh S, Bandukwala S et al (2013) Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis 9:370–378CrossRef Lakadawala M, Shaikh S, Bandukwala S et al (2013) Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis 9:370–378CrossRef
25.
Zurück zum Zitat Brethauer SA, Amino A, Ramero-Talamas H et al (2013) Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 258:628–637PubMedPubMedCentral Brethauer SA, Amino A, Ramero-Talamas H et al (2013) Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 258:628–637PubMedPubMedCentral
26.
Zurück zum Zitat Li J, Lai D, Wu D (2016) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg 26:429–442CrossRefPubMed Li J, Lai D, Wu D (2016) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg 26:429–442CrossRefPubMed
27.
Zurück zum Zitat Yousseif A, Emmanuel J, Karra E, Millet Q, Elkalaawy M, Jenkinson AD et al (2014) Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg 24(2):241–252CrossRefPubMed Yousseif A, Emmanuel J, Karra E, Millet Q, Elkalaawy M, Jenkinson AD et al (2014) Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg 24(2):241–252CrossRefPubMed
28.
Zurück zum Zitat Thaler JP, Cummings DE (2009) Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150:2518–2525CrossRefPubMed Thaler JP, Cummings DE (2009) Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150:2518–2525CrossRefPubMed
29.
Zurück zum Zitat Jullg M, Yip S, Xu A et al (2014) Lower Fetulin-A retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes. PLoS One 9(5):e96489CrossRef Jullg M, Yip S, Xu A et al (2014) Lower Fetulin-A retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes. PLoS One 9(5):e96489CrossRef
30.
Zurück zum Zitat Couupaye M, Riviere P, Breuil MC et al (2014) Comparison of nutritional status during the first year after sleeve gastrectomy an Roux-en-Y gastric bypass. Obes Surg 24:276–283CrossRef Couupaye M, Riviere P, Breuil MC et al (2014) Comparison of nutritional status during the first year after sleeve gastrectomy an Roux-en-Y gastric bypass. Obes Surg 24:276–283CrossRef
31.
Zurück zum Zitat Fang YL, Almulaifi AM, Lee WJ (2015) Letter to “predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis”. Obes Surg 25:2424–2425CrossRefPubMed Fang YL, Almulaifi AM, Lee WJ (2015) Letter to “predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis”. Obes Surg 25:2424–2425CrossRefPubMed
32.
Zurück zum Zitat Lee WJ, Chong K, Chen SC et al (2016) Pre-operative prediction of type 2 diabetes remission after gastric bypass surgery: a comparison of DiaRem scores and ABCD scores. Obes Surg. doi:10.1007/s11695-016-2120-5 Lee WJ, Chong K, Chen SC et al (2016) Pre-operative prediction of type 2 diabetes remission after gastric bypass surgery: a comparison of DiaRem scores and ABCD scores. Obes Surg. doi:10.​1007/​s11695-016-2120-5
Metadaten
Titel
Metabolic Surgery for Diabetes Treatment: Sleeve Gastrectomy or Gastric Bypass?
verfasst von
Wei-Jei Lee
Keong Chong
Lwin Aung
Shu-Chun Chen
Kong-Han Ser
Yi-Chih Lee
Publikationsdatum
22.08.2016
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 1/2017
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3690-z

Weitere Artikel der Ausgabe 1/2017

World Journal of Surgery 1/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.